4-(Chloromethyl)-5-hydroxy-7-methyl-2H-chromen-2-one, 90.0%, 1g

1-N-Boc-4-(3-Aminomethylpyridyl)piperidine, 98.0%, 1g

Diisopropilamina, min 99,5%, para síntesis, 2,5L, envase de vidrio

4'-Benzyloxy-biphenyl-2-ylamine, 95.0%, 5g

4,5-Difluoro-3-hydroxyisobenzofuran-1(3H)-one, 98%, 1g

Guardcolumnas HPLC (analíticas) NUCLEODUR® 100-5 C18 ec, 4 x 3 mm, 3 Pieza(s)

5-(4-methylphenyl)imidazolidine-2,4-dione, 95.0%, 1g

6-Bromo-7-fluoro-1H-indazole, 95%, 5g

2-chloro-5-(1H-1,2,3,4-tetrazol-5-yl)pyridine, 98%, 100mg

1-Iodo-2-(2-methoxyethoxy)ethane, 95.0%, 1g

2-Fluoro-3-methylbenzenesulfonyl chloride, 99.0%, 10g

2-(Tert-butoxy)-5-fluoroaniline, 97%, 1g

(2R,5R)-tert-Butyl 5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate, 95.0%, 100mg